Contact this trialFirst, we need to learn more about you.
Investigational Drug for Schizophrenia
Recruiting2 awardsPhase 3
Rogers, Arkansas
This trial is to study the long-term safety of an investigational drug for people with schizophrenia. The study is open to males and females between 13-65 years old who have completed Study SEP361-301 or SEP361-302. The study will last one year and will be conducted at 80 study centers worldwide.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.